Target expression details
Target General Information | |||||
---|---|---|---|---|---|
Target ID | T72038 | ||||
Target Name | Galectin-3 | ||||
Synonyms | 35 kDa lectin; Beta-galactoside-binding protein LGALS3; CBP 35; Carbohydrate binding protein 35; GALBP; Galactose-specific lectin 3; Galactoside-binding protein; IgE-binding protein; L-31; Laminin-binding protein; Lectin L-29; Mac-2 antigen; LGALS3 | ||||
Target Type | Clinical Trial | ||||
Gene Name | LGALS3 | ||||
UniProt ID | LEG3_HUMAN | ||||
Target Gene Expression Profiles in the Disease-Relevant Drug Targeted Tissue of the Patients and Healthy Individuals | |||||
Disease | Melanoma | ||||
Example drug | GR-MD-02 | Phase 2 | [525159], [1572592] | ||
Tissue | Skin | ||||
Level of differential expression between the patients in the disease section of the tissue and the tissues of healthy individual | Fold-change: -0.05 Z-score: -0.08 P-value: 4.24E-01 |
||||
Target gene expression profiles of the patients in the disease section of the tissue
Target gene expression profiles in the tissue of healthy individual
|
If You Find Any Error in Data or Bug in Web Service, Please Kindly Report It to Dr. Zhou and Dr. Zhang.